Promoter regulation of the visinin-like subfamily of neuronal calcium sensor proteins by nuclear respiratory factor-1.
VILIP-1 (gene name VSNL1), a member of the neuronal Ca(2+) sensor protein family, acts as a tumor suppressor gene by inhibiting cell proliferation, adhesion, and invasiveness. VILIP-1 expression is down-regulated in several types of human cancer. In human non-small cell lung cancer, we found that down-regulation was due to epigenetic changes. Consequently, in this study we analyzed the VSNL1 promoter and its regulation. Serial truncation of the proximal 2-kb VSNL1 promoter (VP-1998) from its 5' terminus disclosed that the last 3' terminal 100-bp promoter fragment maintained similar promoter activity as compared with VP-1998 and therefore was referred to as VSNL1 minimal promoter. When the 5' terminal 50 bp were deleted from the minimal promoter, the activity was dramatically decreased, suggesting that the deleted 50 bp contained a potential cis-acting element crucial for promoter activity. Deletion and site-directed mutagenesis combined with in silico transcription factor binding analysis of VSNL1 promoter identified nuclear respiratory factor (NRF)-1/alpha-PAL as a major player in regulating VSNL1 minimal promoter activity. The function of NRF-1 was further confirmed using dominant-negative NRF-1 overexpression and NRF-1 small interfering RNA knockdown. Electrophoretic mobility shift assay and chromatin immunoprecipitation provided evidence for direct NRF-1 binding to the VSNL1 promoter. Methylation of the NRF-1-binding site was found to be able to regulate VSNL1 promoter activity. Our results further indicated that NRF-1 could be a regulatory factor for gene expression of the other visinin-like subfamily members including HPCAL4, HPCAL1, HPCA, and NCALD.
Fu
Jian
J
Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Zhang
Jirong
J
Jin
Fang
F
Patchefsky
Jamie
J
Braunewell
Karl-Heinz
KH
Klein-Szanto
Andres J
AJ
D000818:Animals; D001665:Binding Sites; D045744:Cell Line, Tumor; D047369:Chromatin Immunoprecipitation; D004247:DNA / Q000378:metabolism; D005786:Gene Expression Regulation; D055785:Gene Knockdown Techniques; D006801:Humans; D008745:Methylation; D051596:Neurocalcin / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism; D051266:Nuclear Respiratory Factor 1 / Q000378:metabolism*; D011401:Promoter Regions, Genetic / Q000235:genetics*; D034741:RNA, Small Interfering / Q000235:genetics; D017384:Sequence Deletion; D014158:Transcription, Genetic; D014162:Transfection
D051596:Neurocalcin; D051266:Nuclear Respiratory Factor 1; D034741:RNA, Small Interfering; C496688:VSNL1 protein, human; D004247:DNA
J Biol Chem. 2006 Jan 6;281(1):324-33
16230352
Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R50-9
17613547
PLoS One. 2008 Feb 27;3(2):e1698
18301774
Hum Mol Genet. 2004 Aug 1;13(15):1611-21
15175277
Genome Res. 2004 Aug;14(8):1562-74
15256515
J Cell Sci. 2006 Aug 1;119(Pt 15):3033-7
16868031
Development. 1998 Nov;125(22):4369-78
9778497
Nucleic Acids Res. 1990 Jul 11;18(13):3975-82
1695733
Biochem J. 2003 Aug 1;373(Pt 3):713-22
12720548
J Cell Physiol. 2007 Nov;213(2):384-90
17708532
Nat Rev Neurosci. 2007 Mar;8(3):182-93
17311005
Neuron. 2005 Aug 18;47(4):487-94
16102532
Biochem J. 2004 Nov 1;383(Pt. 3):529-36
15257658
J Biol Chem. 2001 Feb 9;276(6):4357-64
11058604
Cancer Res. 2003 Aug 15;63(16):4997-5004
12941826
J Biol Chem. 2006 Aug 4;281(31):21942-21953
16731532
Gene. 2007 Apr 15;391(1-2):198-208
17300881
J Biol Chem. 2004 Apr 9;279(15):14542-50
14747477
Cell Tissue Res. 1999 Jan;295(1):1-12
9931348
Mol Carcinog. 2006 Aug;45(8):572-81
16683251
Mol Cell Biol. 1993 Jun;13(6):3641-9
8388540
Cell. 1999 Jul 9;98(1):115-24
10412986
Biochim Biophys Acta. 2002 Nov 4;1600(1-2):118-27
12445467
J Biol Chem. 2004 Nov 5;279(45):46954-61
15308624
Oncogene. 2005 Mar 31;24(14):2307-16
15735716
Mol Cell. 2004 Nov 5;16(3):399-411
15525513
Mol Cell Biol. 2001 Jun;21(11):3738-49
11340167
Biochim Biophys Acta. 2002 Apr 12;1574(3):359-64
11997103
Trends Pharmacol Sci. 2005 Jul;26(7):345-51
15982480
J Neurosci. 1998 Sep 1;18(17):6723-39
9712644
Gene. 2008 Feb 29;410(1):197-206
18234454
Biochem Biophys Res Commun. 2004 Sep 24;322(3):1073-9
15336574
J Cell Biochem. 2006 Mar 1;97(4):673-83
16329141
Physiol Rev. 2008 Apr;88(2):611-38
18391175
Genes Dev. 2006 Dec 1;20(23):3215-31
17158741
J Mol Biol. 1987 Jul 20;196(2):261-82
3656447
Biochem Biophys Res Commun. 2004 Jan 30;314(1):118-22
14715254
Biochem Biophys Res Commun. 2004 Oct 8;323(1):38-43
15351697
Genome Biol. 2008 Apr 17;9(4):R73
18419806
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1309-13
8108407
J Biol Chem. 2008 Apr 18;283(16):10967-77
18252725
Cell Tissue Res. 2009 Feb;335(2):301-16
18989702
Mol Cell Biol. 2005 Feb;25(4):1354-66
15684387
Neuropharmacology. 2003 May;44(6):707-15
12681369
Oncogene. 1995 Jun 1;10(11):2185-94
7784063
BMC Genomics. 2008 Feb 05;9:67
18252004
Biochem Cell Biol. 2008 Feb;86(1):46-56
18364745
Oncogene. 2007 Aug 13;26(37):5433-8
17694084
J Biol Chem. 2002 Jan 18;277(3):1645-8
11733490
Neuroscience. 2005;133(2):471-84
15878804
J Neurocytol. 1999 Aug;28(8):655-62
10851344
Mol Cell Biol. 2001 Jan;21(2):644-54
11134350
Genes Dev. 2004 Feb 15;18(4):357-68
15004004